SXT Pharmaceuticals(US:SXTC) Jin Rong Jie·2025-07-31 13:49Core Viewpoint - Su Xuan Tang (SXTC) is experiencing a stock price increase and has reported a decline in revenue but a significant improvement in net profit, indicating potential operational challenges and cost management success [1]. Financial Performance - As of September 30, 2024, Su Xuan Tang reported total revenue of $829,500, representing a year-over-year decrease of 11.72% [1]. - The company recorded a net profit attributable to shareholders of -$802,600, which shows a year-over-year increase of 91.72% [1]. Company Overview - Su Xuan Tang Pharmaceutical Co., Ltd. is an innovative Chinese pharmaceutical company focused on the research, production, and sales of traditional Chinese medicine (TCM) decoction pieces, particularly modern TCM products for direct oral consumption and infusion [1]. - TCM decoction pieces have been widely used in China for thousands of years, highlighting the company's engagement in a long-standing industry [1].